AG0039L7

1032568-63-0 | 2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide

AG0039L7

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

• mg
• g
• kg
• ml
• L

No data

• mg
• g
• kg
• ml
• L

No data

No data

Inquire

CAS Number	1032568-63-0
Catalog Number	AG0039L7(AGN-PC-0WAJFZ)
Chemical Name	2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide
IUPAC Name	2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide
InChI	InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27)
InChI Key	MWYDSXOGIBMAET-UHFFFAOYSA-N
MDL Number	MFCD18633201
Molecular Formula	C23H28N8O4
Molecular Weight	480.5196
SMILES	NC1=NC=C(C=N1)C(=O)NC1=NC=2C(=C(C=CC2C=2N1CCN2)OCCCN2CCOCC2)OC
UNII	WI6V529FZ9
Synonyms	2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo(1,2-c)quinazolin-4-yl)pyrimidine-5-carboxamide, BAY 80-6946, copanlisib, Copanlisib, 1032568-63-0, BAY 80-6946, BAY-80-6946, Aliqopa, BAY80-6946, UNII-WI6V529FZ9, BAY 80-6946 (Copanlisib), WI6V529FZ9, Copanlisib (BAY 80-6946), 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide, AK172384, 2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide, 2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide, Copanlisib (USAN/INN), Copanlisib [USAN:INN], GTPL7875, SCHEMBL1655478, BAY 80-6946; Copanlisib, CHEMBL3218576, SCHEMBL13084037, DTXSID00145728, PZBCKZWLPGJMAO-UHFFFAOYSA-N, C23H28N8O4, BCP04754, EX-A2005, 2253AH, BDBM50204093, MFCD18633201, s2802, ZINC68247389, AKOS025290222, BAY-806946, CS-0741, DB12483, PB22956, VS-0128, KS-0000079U, NCGC00346457-01, NCGC00346457-04, 4CA-0259, AC-28438, HY-15346, QC-10511, A11766, D10867, Q-4031, 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1.2-c]quinazolin-5-yl]pyrimidine-5-carboxamide, BAY-80-6946|||2-Amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide, copanlisib HCl, Copanlisib [INN], Copanlisib hydrochloride, D0S5LD, copanlisib hydrochloride hydrate, BAY 84-1236, B2178, 1187594-09-7, 2-Azanyl-~{n}-[7-Methoxy-8-(3-Morpholin-4-Ylpropoxy)-2,3-Dihydroimidazo[1,2-C]quinazolin-5-Yl]pyrimidine-5-Carboxamide,

Complexity	974
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	480.223g/mol
Formal Charge	0
Heavy Atom Count	35
Hydrogen Bond Acceptor Count	9
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	480.529g/mol
Monoisotopic Mass	480.223g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	140A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number